GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxxinity Inc (OTCPK:VAXX) » Definitions » Price-to-Tangible-Book

Vaxxinity (Vaxxinity) Price-to-Tangible-Book : 0.52 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vaxxinity Price-to-Tangible-Book?

As of today (2024-05-16), Vaxxinity's share price is $0.0555. Vaxxinity's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.11. Hence, Vaxxinity's Price to Tangible Book Ratio of today is 0.52.

The historical rank and industry rank for Vaxxinity's Price-to-Tangible-Book or its related term are showing as below:

VAXX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.41   Med: 5.47   Max: 8.02
Current: 0.5

During the past 5 years, Vaxxinity's highest Price to Tangible Book Ratio was 8.02. The lowest was 0.41. And the median was 5.47.

VAXX's Price-to-Tangible-Book is ranked better than
94.8% of 1231 companies
in the Biotechnology industry
Industry Median: 2.81 vs VAXX: 0.50

A closely related ratio is called PB Ratio. As of today, Vaxxinity's share price is $0.0555. Vaxxinity's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.11. Hence, Vaxxinity's P/B Ratio of today is 0.52.


Vaxxinity Price-to-Tangible-Book Historical Data

The historical data trend for Vaxxinity's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxxinity Price-to-Tangible-Book Chart

Vaxxinity Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 5.47 2.84 8.02

Vaxxinity Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.84 6.20 9.13 7.33 8.02

Competitive Comparison of Vaxxinity's Price-to-Tangible-Book

For the Biotechnology subindustry, Vaxxinity's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxxinity's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxxinity's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Vaxxinity's Price-to-Tangible-Book falls into.



Vaxxinity Price-to-Tangible-Book Calculation

Vaxxinity's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.0555/0.106
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Vaxxinity Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Vaxxinity's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxxinity (Vaxxinity) Business Description

Traded in Other Exchanges
N/A
Address
505 Odyssey Way, Merritt Island, FL, USA, 32953
Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications.
Executives
Sumita Ray officer: Chief Legal Officer, Secretary C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Prime Movers Lab Fund I Lp 10 percent owner P.O. BOX 12829, JACKSON WY 83002
Landon E Ogilvie director 505 ODYSSEY WAY, EXPLORATION PARK FL 32953
Katherine A. Eade director C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
James Alan Smith director 505 ODYSSEY WAY, EXPLORATION PARK FL 32953
Gabrielle B Toledano director 209 REDWOOD SHORES PARKWAY, REDWOOD CITY CA 94065
Lou Reese director, officer: Executive Chairman C/O VAXXINITY, INC., 1717 MAIN ST STE. 3388, DALLAS TX 75201
Mei Mei Hu director, 10 percent owner, officer: See Remarks C/O VAXXINITY, INC., 1717 MAIN ST STE. 3388, DALLAS TX 75201
United Biomedical Inc 10 percent owner 25 DAVIDS DR, HAUPPAUGE NY 11788
Dakin Sloss 10 percent owner 126 E 56TH ST, 30TH FLOOR, NEW YORK NY 10022
Peter Powchik director REGENERON PHARMACEUTICALS, INC., 777 OLD SAW MILL RIVER ROAD, TARRYTOWN NY 10591
Jason Pesile officer: See Remarks C/O VAXXINITY, INC., 1717 MAIN ST. STE.3388, DALLAS TX 75201
George R Hornig director 625 MADISON AVE SUITE 10-B, NEW YORK NY 10017
James Chui director C/O VAXXINITY, INC., 1717 MAIN ST STE. 3388, DALLAS TX 75201
Peter Diamandis director 4640 ADMIRALTY WAY, SUITE 500, MARINA DEL REY CA 90292

Vaxxinity (Vaxxinity) Headlines